Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:072020)

KOSDAQ:072020 Revenue

Choong Ang Vaccine Laboratory had revenue of 10.23B KRW in the quarter ending March 31, 2023, a decrease of -1.05%. This brings the company's total for the last twelve months to 39.19B, down -4.18% year-over-year. In the year 2022, Choong Ang Vaccine Laboratory had annual revenue of 39.30B, down -3.95%. That makes Choong Ang Vaccine Laboratory the 31,532nd largest company in the world by revenue and 1,991st in South Korea.

• Revenue (ttm): 39.19B
• Revenue Growth: -4.18%
• P/S Ratio: 2.12
• Revenue / Employee: 234.67M
• Employees: 167
• Market Cap: 82.39B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 23.36B 59.4%
• Asia 15.47B 39.4%
• Africa 469.08M 1.2%

Fiscal year ended Dec 31, 2022

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2022	39.30B	-1.61B	-3.95%
Dec 31, 2021	40.91B	4.60B	12.66%
Dec 31, 2020	36.32B	17.05B	88.53%
Dec 31, 2012	19.26B	3.67B	23.57%
Dec 31, 2011	15.59B	-507.67M	-3.15%

Data Source: S&P Global Market Intelligence Last updated: May 15, 2023

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error